Biopharmaceutics and Interpharm
Executive Summary
Former VP Abu Quamruzzaman sentenced to nine months in prison in Baltimore federal court Oct. 14. Quamruzzaman pled guilty in July to submitting false information on Biopharmaceutic's ANDA for clindamycin 150 mg capsules; he also filed false data in Interpharm ANDAs. Biopharmaceutics pled guilty in July to submission of false information to FDA ("The Pink Sheet" July 12, T&G-13).